Changeflow GovPing Healthcare & Life Sciences Ultrasound-guided Percutaneous Electrolysis for...
Routine Notice Added Final

Ultrasound-guided Percutaneous Electrolysis for Hip Impingement (NCT07548034)

Favicon for changeflow.com ClinicalTrials.gov Studies
Published
Detected
Email

Summary

This document registers clinical trial NCT07548034, which will evaluate the effectiveness of ultrasound-guided percutaneous electrolysis combined with a therapeutic exercise program compared to exercise alone for the treatment of femoroacetabular impingement syndrome. The five-week study will assess outcomes including pain intensity, hip mobility, and hip function. Participants will be divided into two groups receiving either the combined intervention or exercise alone.

“This study aims to evaluate the effectiveness of ultrasound-guided percutaneous electrolysis, a minimally invasive physiotherapy technique, when combined with a therapeutic exercise program.”

NIH , verbatim from source
Published by NIH on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.

What changed

This document registers a clinical trial (NCT07548034) evaluating ultrasound-guided percutaneous electrolysis combined with therapeutic exercise versus therapeutic exercise alone for femoroacetabular impingement syndrome. The five-week study will measure pain intensity, hip mobility, and hip function as primary outcomes. Clinical investigators researching hip impingement or invasive physiotherapy techniques should monitor this trial for emerging evidence on treatment effectiveness.

Archived snapshot

Apr 24, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← ClinicalTrials.gov Studies

Ultrasound-guided Percutaneous Electrolysis With Therapeutic Exercise in Femoroacetabular Impingement Syndrome

N/A NCT07548034 Kind: NA Apr 23, 2026

Abstract

Hip pain is a common condition that can affect both athletes and the general population. One of the most frequent causes of pain in the front of the hip is a condition known as femoroacetabular impingement (FAI). This occurs when there is an abnormal contact between the bones of the hip joint, which may lead to pain, stiffness, and reduced mobility. In many cases, this pain is also related to surrounding soft tissues, especially the iliopsoas muscle and tendon, which play an important role in hip movement.

Although surgery is sometimes used to treat this condition, many patients can benefit from conservative (non-surgical) treatment such as physiotherapy. However, there is still limited evidence on the effectiveness of certain advanced physiotherapy techniques, particularly invasive approaches.

This study aims to evaluate the effectiveness of ultrasound-guided percutaneous electrolysis, a minimally invasive physiotherapy technique, when combined with a therapeutic exercise program. This technique involves the application of a small electrical current through a fine needle to targeted soft tissues, with the goal of reducing pain and improving tissue function.

Participants in this study will be divided into two groups. One group will receive both percutaneous electrolysis and a structured exercise program, while the other group will perform the exercise program alone. The study will last five weeks, and outcomes such as pain intensity, hip mobility, and hip function will ...

Conditions: Femoro Acetabular Impingement, Hip Pain, Iliopsoas Syndrome, Groin Pain

Interventions: Ultrasound-guided percutaneous needle electrolysis, Therapeutic exercise program

View original document →

Get daily alerts for ClinicalTrials.gov Studies

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from NIH.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
NIH
Published
April 23rd, 2026
Instrument
Notice
Branch
Executive
Legal weight
Non-binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Healthcare providers Clinical investigators
Industry sector
6211 Healthcare Providers
Activity scope
Clinical trial registration Interventional study
Geographic scope
United States US

Taxonomy

Primary area
Healthcare
Operational domain
Clinical Operations
Topics
Pharmaceuticals Medical Devices

Get alerts for this source

We'll email you when ClinicalTrials.gov Studies publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!